Crystallization and preliminary neutron diffraction experiment of human farnesyl pyrophosphate synthase complexed with risedronate

Acta Crystallogr F Struct Biol Commun. 2014 Apr;70(Pt 4):470-2. doi: 10.1107/S2053230X14004087. Epub 2014 Mar 25.

Abstract

Nitrogen-containing bisphosphonates (N-BPs), such as risedronate and zoledronate, are currently used as a clinical drug for bone-resorption diseases and are potent inhibitors of farnesyl pyrophosphate synthase (FPPS). X-ray crystallographic analyses of FPPS with N-BPs have revealed that N-BPs bind to FPPS with three magnesium ions and several water molecules. To understand the structural characteristics of N-BPs bound to FPPS, including H atoms and hydration by water, neutron diffraction studies were initiated using BIODIFF at the Heinz Maier-Leibnitz Zentrum (MLZ). FPPS-risedronate complex crystals of approximate dimensions 2.8 × 2.5 × 1.5 mm (∼3.5 mm(3)) were obtained by repeated macro-seeding. Monochromatic neutron diffraction data were collected to 2.4 Å resolution with 98.4% overall completeness. Here, the first successful neutron data collection from FPPS in complex with N-BPs is reported.

Keywords: farnesyl pyrophosphate synthase; neutron protein crystallography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Crystallization / methods*
  • Crystallography, X-Ray
  • Etidronic Acid / analogs & derivatives*
  • Etidronic Acid / chemistry
  • Etidronic Acid / metabolism
  • Geranyltranstransferase / chemistry*
  • Geranyltranstransferase / metabolism*
  • Humans
  • Models, Molecular
  • Neutron Diffraction / methods*
  • Polyisoprenyl Phosphates / chemistry
  • Polyisoprenyl Phosphates / metabolism
  • Protein Conformation
  • Risedronic Acid
  • Sesquiterpenes / chemistry
  • Sesquiterpenes / metabolism

Substances

  • Polyisoprenyl Phosphates
  • Sesquiterpenes
  • farnesyl pyrophosphate
  • Geranyltranstransferase
  • Risedronic Acid
  • Etidronic Acid